GOAL
The educational goal of this activity is to improve the knowledge, competence, and performance of ophthalmologists in managing patients with open-angle glaucoma with emphasis on early detection, risk for progression, and patient adherence to treatment.
OVERVIEW
Optimal open-angle glaucoma management includes 3 main components: early diagnosis, detection of progression, and appropriate treatment. Each of these components has its own difficulties and roadblocks. Improving performance in any of these components, separately or in combination, would be beneficial to patients and visual outcomes.
What are the issues with each of these components? Is there room for improvement? How can we achieve better outcomes?
This activity will try to answer these questions and provide insights that may help practicing ophthalmologists deliver better care to their patients.
INTENDED AUDIENCE
This activity is designed for ophthalmologists. No prerequisites required.
FACULTY
David S. Friedman, MD, MPH, PhD (Chair)
Professor
Wilmer Eye Institute and Bloomberg School of Public Health
Senior Ophthalmologist, Helen Keller International
Baltimore, Maryland
David S. Greenfield, MD
Professor of Ophthalmology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, Florida
Christopher Girkin, MD
Professor of Ophthalmology
Department of Ophthalmology
University of Alabama at Birmingham
Callahan Eye Foundation Hospital
Birmingham, Alabama
CME INFORMATION
Accreditation Statement — The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement — The Johns Hopkins University School of
Medicine designates this educational activity for a maximum of 1.5 AMA
PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
After reviewing this online activity, participants may receive credit by completing the CME test, evaluation, and receiving a score of 70% or higher.
The estimated time to complete this activity: 1.5 hours.
Release date: December 30, 2009. Expiration date: December 30, 2011.
Activity Format — Archived webcast of a symposium held at the AAO/PAAO Joint Meeting.
Fee Information — There is no fee for this educational activity.
Full Disclosure Policy Affecting CME Activities —As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Participating Faculty reported the following:
Dr Friedman reports serving as a consultant for Pfizer Inc and receiving an instrument loan from Carl Zeiss Meditec.
Dr Girkin reports having no relationships with commercial interests related to this activity.
Dr Greenfield reports receiving grants/research support from Alcon, Inc, Allergan, Inc, Carl Zeiss Meditec, Heidelberg Engineering, Optovue Inc, Pfizer Inc, and Topcon Inc; serving as a consultant for and receiving honoraria from Alcon, Inc, Allergan, Inc, Optovue Inc, Pfizer Inc, and Topcon Inc; and receiving research instruments from Carl Zeiss Meditec, Heidelberg Engineering, Optovue Inc, and Topcon Inc.
Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grant, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).
OFF-LABEL PRODUCT DISCUSSION – No speaker has indicated that their presentation will include information on off-label products.
Disclaimer —The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This archived webcast is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.
Internet CME Policy —The Office of Continuing Medical Education (CME) at The Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University School of Medicine CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. Continuing Medical Education at The Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based activity. Your information will never be given to anyone outside of The Johns Hopkins University School of Medicine’s CME activity. CME collects only the information necessary to provide you with the services that you request.
| Pre-Test
Conference Goals
David S. Friedman, MD, MPH, PhD (Chair)
Early Glaucoma Diagnosis
David S. Greenfield, MD
Detecting Progression
Christopher Girkin, MD
Barriers to Adherence with Glaucoma Therapy: Causes and Solutions
David S. Friedman, MD, MPH, PhD
Concluding Remarks and Post-Assessment
David S. Friedman, MD, MPH, PhD
Post-Test |
|
|
